Status:
RECRUITING
Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation
Lead Sponsor:
Insel Gruppe AG, University Hospital Bern
Conditions:
Ischemic Stroke
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Brief Summary
Background Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting up to 10% of the elderly. Ischemic stroke is the main complication of AF and cardioembolism is one of the leading ...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Written informed consent (by patient, next of kin or legally authorised representative)
- Permanent, persistent, or paroxysmal AF previously known or diagnosed during the index hospitalisation
- Acute (≤7 days), symptomatic ischemic stroke
Exclusion
- Life expectancy \<1 year according to the opinion of the investigator
- Patient is unlikely to attend follow-up visits
Key Trial Info
Start Date :
November 4 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2028
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06954610
Start Date
November 4 2025
End Date
June 30 2028
Last Update
November 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Inselspital Bern
Bern, Switzerland, 3010